Acute interstitial nephritis due to acute pyelonephritis in a young woman: diagnostic utility of CK7 and CD10 immunostaining

年轻女性急性肾盂肾炎引起的急性间质性肾炎:CK7和CD10免疫染色诊断价值

阅读:1

Abstract

Acute Interstitial Nephritis (AIN) is a common cause of acute kidney injury (AKI) and may lead to irreversible renal scarring if the diagnosis is delayed. Although most cases are drug-induced, AIN can also occur in association with acute pyelonephritis (APN). Nevertheless, given that antibiotics are routinely administered for APN, cases of APN-associated AIN may be erroneously classified as drug-induced AIN. Distinguishing these two entities histologically remains challenging; however, their therapeutic strategies differ. We describe a case involving a previously healthy 21-year-old woman who presented with a fever and rapidly progressive renal impairment. Laboratory evaluation revealed serum creatinine and C-reactive protein concentrations of 3.54 mg/dL and 25.06 mg/dL, respectively, prompting an urgent renal biopsy. Histopathological examination by light microscopy demonstrated a diffuse interstitial and tubular inflammatory infiltrate predominantly composed of neutrophils, consistent with AIN. Based on these pathological findings and the clinical course, AIN secondary to APN was suspected. The patient was managed with an intensified antibiotic regimen without corticosteroid therapy, resulting in complete renal recovery. To further refine the diagnosis after hospital discharge, we examined immunostaining patterns across tubular segments. Immunostaining demonstrated a neutrophil-predominant infiltrate in the distal tubules and collecting ducts, which showed a segmental pattern characteristic of APN-related injury. This case highlights the potential utility of immunostaining in distinguishing APN-associated AIN from drug-induced AIN and supports its incorporation into diagnostic evaluation.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。